Booth Thomas C, Larkin Timothy J, Yuan Yinyin, Kettunen Mikko I, Dawson Sarah N, Scoffings Daniel, Canuto Holly C, Vowler Sarah L, Kirschenlohr Heide, Hobson Michael P, Markowetz Florian, Jefferies Sarah, Brindle Kevin M
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom.
PLoS One. 2017 May 17;12(5):e0176528. doi: 10.1371/journal.pone.0176528. eCollection 2017.
To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T2-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs).
Using a retrospective patient cohort (n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort.
The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T2-weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression.
Analysis of heterogeneity, in T2-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.
通过使用称为闵可夫斯基泛函(MFs)的图像异质性拓扑描述符分析T2加权图像中的肿瘤异质性,开发一种区分假性进展与真性进展的图像分析技术。
使用回顾性患者队列(n = 50),在对治疗反应结果不知情的情况下,进行无监督特征估计,以研究MFs是否存在异常值、潜在混杂因素以及对治疗反应的敏感性。然后对进展组和假性进展组进行揭盲,并使用MFs、大小和信号强度特征进行监督特征选择。获得支持向量机模型并使用前瞻性测试队列进行评估。
在回顾性和前瞻性数据集中,使用MFs和大小特征的组合,该模型的分类准确率均超过85%。不同的特征选择方法(随机森林)和分类器(套索)给出了相同的结果。与假性进展患者相比,进展患者的T2加权高信号表型虽然对报告放射科医生不明显,但具有异质性、大且呈叶状。
分析临床常规采集的T2加权MR图像中的异质性,有可能检测到更早的治疗反应,从而允许早期改变治疗策略。需要在更大的数据集中对该技术进行前瞻性验证。